Xilio Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Xilio Therapeutics's estimated annual revenue is currently $16.1M per year.
- Xilio Therapeutics's estimated revenue per employee is $169,684
- Xilio Therapeutics's total funding is $233M.
- Xilio Therapeutics's current valuation is $398.8M. (January 2022)
Employee Data
- Xilio Therapeutics has 95 Employees.
- Xilio Therapeutics grew their employee count by -10% last year.
Xilio Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP, Head Investor Relations & Corporate Communications | Reveal Email/Phone |
3 | VP, Head Human Resources | Reveal Email/Phone |
4 | SVP Clinical Operations | Reveal Email/Phone |
5 | VP, Drug Discovery | Reveal Email/Phone |
6 | VP Translational Sciences | Reveal Email/Phone |
7 | SVP Program Leadership and Regulatory | Reveal Email/Phone |
8 | VP Biologics | Reveal Email/Phone |
9 | SVP, IT | Reveal Email/Phone |
10 | VP, Commercial Strategy and Planning | Reveal Email/Phone |
Xilio Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Xilio Therapeutics?
Xilio is a Waltham, Massachusetts-based biopharmaceutical company focused on defeating cancer. The company?s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body ? a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer. To learn more, please visit www.xiliotx.com.
keywords:N/A
$233M
Total Funding
95
Number of Employees
$16.1M
Revenue (est)
-10%
Employee Growth %
$398.8M
Valuation
N/A
Accelerator
Xilio Therapeutics News
Most types of targeted therapies help to treat cancer by ... For instance, Xilio Therapeutics, a biotechnology company entered into a...
Xilio Therapeutics' (NASDAQ:XLO Get Rating) lock-up period is set to end ... Xilio Therapeutics had issued 7,353,000 shares in its IPO on...
Xilio Therapeutics aims to improve on cytokine safety with a mask that stays on the therapy until it reaches the tumor microenvironment.
Other Companies in Waltham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $13.9M | 96 | 7% | N/A |
#2 | $14.9M | 96 | 22% | N/A |
#3 | $16.4M | 98 | 9% | $129.3M |
#4 | $13.3M | 99 | 4% | N/A |
#5 | $28.7M | 99 | 62% | N/A |